Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Namita Ruhela
Observed institution:
University of Aruba
ORCID:
0009-0005-8648-4134
Observed ORCID:
0009-0005-8648-4134
OpenAlex ID:
A5118701218
The Triglyceride-Glucose Index: A Novel Marker for Clinical Atherosclerotic Cardiovascular Disease Risk Stratification
2025
·
Rahul Chikatimalla
, Namita Ruhela
, et al.
·
Annals of African Medicine
·
5
Statins and kidney health: exploring cardiovascular benefits, renal protection, and risks in chronic kidney disease
2025
·
Rahul Chikatimalla
, Yash Vardhan Trivedi
, et al.
·
Postgraduate Medicine
·
4
Cystatin C in chronic kidney disease: enhancing diagnostic accuracy and patient outcomes
2026
·
Shrujal Patel
, Mayank Dhalani
, et al.
·
Postgraduate Medicine
·
3
Advancements in lipid-lowering therapy: the role of proprotein convertase subtilisin/kexin type 9 inhibitors and beyond in cardiovascular risk reduction
2025
·
Namita Ruhela
, Ankur Singla
, et al.
·
Coronary Artery Disease
·
3
The impact of guided meditations and mindfulness on blood pressure regulation: analyzing the physiological impact of mental health techniques on cardiac biomarkers
2025
·
Gayathri Gururamalingam
, Taruna Ramnath
, et al.
·
Cogent Mental Health
·
1
Abstract 4370064: Cardioembolic Stroke in MELAS Treated with Thrombolysis
2025
·
Yash Vardhan Trivedi
, Papul Chalia
, et al.
·
Circulation
Omega-3 Fatty Acids in Cardiovascular Health: Navigating the Duality of Benefits and Risks
2025
·
Priyanshi Shah
, Twinkle Shah
, et al.
·
Eastern Journal of Medical Sciences
PDF
Show more works
View as search
Works count:
7
Citation count:
16
H-index:
3
I10-index:
Year
Topic
Type
